Ureteric Stent-related Morbidity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ureteric Stent-related Morbidity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedNot Applicable

NCT07307261

Evaluation of Mirabegron Versus Tamsulosin or Their Combination in Treatment of Lower Urinary Tract Symptoms

Stent related symptoms (SRSs) comprise of complaints such as irritative symptoms, sense of incomplete emptying, flank and suprapubic pain, and incontinence. Mec…

Egypt300 participantsStarted 2024-10-10

Treatment: Tamsulosin

CompletedNot Applicable

NCT03217318

Reduction of Stent Associated Morbidity by Minimizing Stent Material.

After providing informed consent, patients will be randomized into one of two groups (single-blinded): Group 1 will receive a standard Percuflex® (Boston scient…

Switzerland92 participantsStarted 2017-07-15

Treatment: ureteral stenting with standard or modified ureteral stent